Revolutionizing Ophthalmic Surgery with Programmable Synthetic Biomaterials
BioOptix is led by a multidisciplinary team of expert ophthalmologists, scientists, and business leaders with deep experience in clinical practice, R&D, operations, and venture investment. We believe that advancing ophthalmic surgical technology can profoundly improve outcomes for millions of patients around the world.
Our vision is better vision
Optimatrix™ OVD
Biocompatible, Instantly Dissolvable, and Sustainably Engineered
Since the introduction of OVDs in the 1980s, most innovations have focused on incremental changes to naturally derived materials. Optimatrix™ represents a true leap forward: a fully synthetic, programmable biomaterial that combines cohesive and dispersive properties in a single formulation. It dissolves instantly with cold saline, simplifying removal and reducing postoperative risks—addressing core limitations that have persisted for over four decades.
Optimatrix™ Features
Fully Synthetic and Programmable
Ophthalmic biomaterial combining cohesive and despersive properties, with a viscoelastic profile tailored to each stage of surgery.
Clinically Safe
Biocompatible, biodegradable, and non-immunogenic with supporting safety data from analogous orthopedic and dental uses.
Instant Dissolution
Transforms from gel to liquid with cold salin for complete removal, minimizing risk of post operative complications.
Protected Innovation
Backed by over 40 granted patents, securing IP coverage through 2039 and beyond.
Meet the Team
BioOptix™ is supported by a team of experts
